FIELD: medicine. SUBSTANCE: invention relates to production of medicinal-biological preparations, in part, to oral form of recombinant human erythropoietin used for treatment of different forms of anemia. Form is prepared by mixing erythropoietin with stabilizing additions taken at the definite ratios at erythropoietin dose is 100-2 000 U/tablet followed by lyophilization. Lyophilized erythropoietin is mixed with lactose, calcium sterate and vanillin and pressed to make tablets which are covered then by acid-resistant envelope. Obtained form is more easily for intake. EFFECT: improved properties, increased stability at storage. 2 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
TABLET FORM OF RECOMBINANT HUMAN ERYTHROPOIETIN | 2000 |
|
RU2182830C1 |
METHOD OF PRODUCTION OF SUBSTANCE RECOMBINANT HUMAN ERYTHROPOIETIN AND NANOCAPSULAR FORM OF RECOMBINANT HUMAN ERYTHROPOIETIN WITH USE OF SUBSTANCE OBTAINED BY THIS METHOD | 2012 |
|
RU2518329C1 |
METHOD OF LIVE ANTIMEASLES VACCINE PREPARING | 1996 |
|
RU2123331C1 |
TABLETED LIVE RECOMBINANT BIVACCINE "REVAKS VKT" AGAINST NATURAL SMALLPOX AND HEPATITIS B AND METHOD FOR ITS PREPARING | 2002 |
|
RU2242246C2 |
METHOD OF LIVE ANTIMEASLES VACCINE PREPARING | 1998 |
|
RU2140288C1 |
RECOMBINANT PLASMID DNA PKEP-9 ENCODING HUMAN ERYTHROPOIETIN, STRAIN OF CULTURED CHINESE HAMSTER OVARY CELLS CHOPE-9 - A PRODUCER OF HUMAN ERYTHROPOIETIN | 1997 |
|
RU2118662C1 |
METHOD OF PREPARING THE ENTERAL PREPARATION CONTAINING ALPHA-INTERFERON AND ENTERAL PREPARATION CONTAINING ALPHA-INTERFERON AS TABLETS | 1993 |
|
RU2083222C1 |
LIVE RECOMBINANT VACCINE OF HEPATITIS B BASED ON SMALLPOX VIRUS FOR ORAL USE AND METHOD OF ITS PREPARING | 1994 |
|
RU2076735C1 |
LIPOSOMAL ANTIVIRAL DRUG FOR ORAL USING | 1996 |
|
RU2123328C1 |
PREPARATION FOR TREATING ANEMIA ASSOCIATED WITH A CHRONIC RENAL DISEASE AND METHOD FOR PRODUCTION THEREOF | 2020 |
|
RU2756312C1 |
Authors
Dates
2000-07-10—Published
1997-05-22—Filed